Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) is a specialty biopharmaceutical company primarily focused on developing and commercializing product...
Amedica Agrees to Sell its Commercial Spine Products Business, Analysts Opinion
Amedica Corporation (NASDAQ: AMDA) is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufactur...
Fortress Biotech, Business Model Review, Pipeline, Analysts Opinion and Target
Fortress Biotech, Inc. (NASDAQ: FBIO) is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and b...
Conatus Pharmaceuticals, Upcoming Presentations, Analysts Review and Target
Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) is a biotechnology company, focused on the development and commercialization of novel medicines for the tr...
Short Squeeze? Established Company with Potentially Undervalued Shares
Today we are initiating coverage on KBS Fashion Group Limited (NASDAQ: KBSF), a leading player in the fashion menswear space in China. We believe KBSF...
Laredo Petroleum Shows Consistent Growth and Issues Q3 Guidance, Analysts Review
Laredo Petroleum, Inc. (NYSE: LPI) operates as an independent energy company in the United States. It operates through two segments, Exploration and P...
Tronox Limited, Analyst Targets and Comprehensive Review
Tronox Limited (NYSE: TROX) is a vertically integrated mining and inorganic chemical business. The company mines and processes titanium ore, zircon, a...
Extreme Networks Closing in on a Billion in Revenues, Analysts review and Target
Extreme Networks, Inc. (NASDAQ: EXTR) provides software-driven networking solutions for enterprise customers worldwide. It designs, develops, and manu...
The Green Organic Dutchman Growing Like a Weed Through Partnerships and New Agreements
The Green Organic Dutchman Holdings Ltd. (OTCQX: TGODF) is a research & development company licensed under the Access to Cannabis for Medical Purp...
Lannett Company Moves to Replace Products it May Lose in Supply Agreement Cancellation
Lannett Company, Inc (NYSE: LCI) is a leading manufacturer of over 100 unique pharmaceutical product families that save and enhance people’s lives. LC...